Gossamer Bio Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 78.17. In total, the insiders bought 11 576 031 and sold 1 966 296 GOSS shares in the last 100 trades.

Insider Power

(Last 100 transactions)
78.17
Buy 11 576 031 Shares
Sell 1 966 296 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 24, 2024 Common Stock Sell Aranda Richard 1 908
Jun 21, 2024 Common Stock Buy Hasnain Faheem 372 000
Jun 18, 2024 Common Stock Buy Giraudo Bryan 100 000
Jun 17, 2024 Common Stock Buy Smith Robert Paul Jr 25 000
Jun 06, 2024 Non-qualified stock option (Right to Buy) Buy Quisel John D 115 000
Jun 06, 2024 Non-qualified stock option (Right to Buy) Buy Milligan Sandra 115 000
Jun 06, 2024 Non-qualified stock option (Right to Buy) Buy Cox Russell J. 115 000
Jun 06, 2024 Non-qualified stock option (Right to Buy) Buy Daniel Thomas O 115 000
Mar 27, 2024 Common Stock Sell Christian Waage 6 430
Mar 27, 2024 Common Stock Sell Giraudo Bryan 6 430
Mar 27, 2024 Common Stock Sell Hasnain Faheem 23 172
Mar 18, 2024 Common Stock Sell Aranda Richard 4 018
Mar 18, 2024 Common Stock Sell Peterson Caryn 4 018
Mar 11, 2024 Stock Option (Right to Buy) Buy Drynan Skye 230 000
Mar 11, 2024 Stock Option (Right to Buy) Buy Nathan Steven D 230 000
Mar 11, 2024 Buy Drynan Skye 0
Mar 11, 2024 Buy Nathan Steven D 0
Jan 02, 2024 Stock Option (Right to Buy) Buy Peterson Caryn 375 000
Jan 02, 2024 Stock Option (Right to Buy) Buy Christian Waage 375 000
Jan 02, 2024 Stock Option (Right to Buy) Buy Aranda Richard 487 500
Jan 02, 2024 Stock Option (Right to Buy) Buy Giraudo Bryan 543 750
Jan 02, 2024 Stock Option (Right to Buy) Buy Hasnain Faheem 1 312 500
Dec 04, 2023 Stock Option (Right to Buy) Buy Smith Robert Paul Jr 1 500 000
Dec 04, 2023 Buy Smith Robert Paul Jr 0
Nov 28, 2023 Stock Option (Right to Buy) Buy Quisel John D 230 000
Click to get the best stock tips daily for free!

About Gossamer Bio Inc.

Gossamer Bio. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hy... GOSS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT